9 Stocks on Jim Cramer’s Radar

2. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders: 78

Answering a caller’s inquiry about McKesson Corporation (NYSE:MCK), Cramer commented:

“I’m telling you, I am surprised McKesson hasn’t split the stock, but let’s deal with the fundamentals here. This is one of the strongest stocks in the market because these middlemen are making so much money, and I see no end to that. That’s why I like McKesson so much. Even as some people think, including our president, that they are not playing a valuable role, it doesn’t matter. McKesson is a valuable company, and I think its stock should be bought here, not sold.”

McKesson (NYSE:MCK) delivers healthcare services through drug distribution, medical supply delivery, and logistics management. It offers technology solutions, consulting, and support to biopharma companies, healthcare providers, and patients. Conventum – Alluvium Global Fund stated the following regarding the company in its Q4 2024 investor letter:

“McKesson Corporation (NYSE:MCK), the drug distributor (up 15.4%), released a decent set of results which included management again upgrading its guidance. From the immediate share price reaction together with its subsequent performance we surmise the market’s concerns we spoke of in last quarter’s report have now abated. The new guidance is a little above our view of its maintainable earnings, but we saw no need to change our analysis. With our buying last quarter, it had become the Fund’s largest position until we sold a little in December to now hold 6.3%.”